loadpatents
Patent applications and USPTO patent grants for Hass; Philip E..The latest application filed is for "il-17a/f heterologous polypeptides and therapeutic uses thereof".
Patent | Date |
---|---|
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20220213183 - Arnott; David P ;   et al. | 2022-07-07 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20220213184 - Arnott; David P. ;   et al. | 2022-07-07 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20220204606 - Arnott; David P ;   et al. | 2022-06-30 |
IL-22 Fc fusion proteins Grant 11,332,507 - Scheer , et al. May 17, 2 | 2022-05-17 |
Tie2-binding Agents And Methods Of Use App 20210332142 - YAN; Minhong ;   et al. | 2021-10-28 |
Methods of treating acute pancreatitis using IL-22 fc fusion proteins Grant 11,155,591 - Scheer , et al. October 26, 2 | 2021-10-26 |
Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins Grant 11,136,365 - Scheer , et al. October 5, 2 | 2021-10-05 |
Methods for treating metabolic syndrome using IL-22 Fc fusion proteins Grant 11,130,791 - Scheer , et al. September 28, 2 | 2021-09-28 |
Anti-factor D antibody variant conjugates and uses thereof Grant 10,961,313 - Hass , et al. March 30, 2 | 2021-03-30 |
Anti-interleukin-33 Antibodies And Uses Thereof App 20210002361 - HASS; Philip E. ;   et al. | 2021-01-07 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20200385452 - ARNOTT; David P. ;   et al. | 2020-12-10 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20200377585 - ARNOTT; David P. ;   et al. | 2020-12-03 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20200377584 - ARNOTT; David P. ;   et al. | 2020-12-03 |
Anti-interleukin-33 antibodies and uses thereof Grant 10,723,795 - Hass , et al. | 2020-07-28 |
Anti-factor D antibody variant conjugates and uses thereof Grant 10,654,932 - Hass , et al. | 2020-05-19 |
Anti-factor D Antibody Variant Conjugates And Uses Thereof App 20200115462 - Hass; Philip E. ;   et al. | 2020-04-16 |
Pharmaceutical compositions of IL-22 Fc fusion proteins Grant 10,584,155 - Scheer , et al. | 2020-03-10 |
Methods of accelerating or improving wound healing using IL-22 FC fusion proteins Grant 10,544,198 - Scheer , et al. Ja | 2020-01-28 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190233491 - Scheer; Justin ;   et al. | 2019-08-01 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177387 - Scheer; Justin ;   et al. | 2019-06-13 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177388 - SCHEER; Justin ;   et al. | 2019-06-13 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177386 - SCHEER; Justin ;   et al. | 2019-06-13 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177389 - SCHEER; Justin ;   et al. | 2019-06-13 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20190177390 - Scheer; Justin ;   et al. | 2019-06-13 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20190100583 - ARNOTT; David P. ;   et al. | 2019-04-04 |
Anti-interleukin-33 Antibodies And Uses Thereof App 20190092852 - HASS; Philip E. ;   et al. | 2019-03-28 |
Anti-factor D antibodies Grant 10,179,821 - Kelley , et al. Ja | 2019-01-15 |
Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins Grant 10,160,793 - Scheer , et al. Dec | 2018-12-25 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20180362608 - SCHEER; Justin ;   et al. | 2018-12-20 |
IL-22 Fc FUSION PROTEIN AND METHODS OF USE App 20180355009 - SCHEER; Justin ;   et al. | 2018-12-13 |
Anti-interleukin-33 antibodies and uses thereof Grant 10,093,730 - Hass , et al. October 9, 2 | 2018-10-09 |
Nucleic acids encoding IL-22 Fc fusion proteins Grant 10,087,227 - Scheer , et al. October 2, 2 | 2018-10-02 |
Antibodies directed to IL-17A/IL-17F heterodimers Grant 10,011,654 - Arnott , et al. July 3, 2 | 2018-07-03 |
IL-22 Fc fusion proteins Grant 9,815,880 - Scheer , et al. November 14, 2 | 2017-11-14 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20170320926 - SCHEER; Justin ;   et al. | 2017-11-09 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20170291940 - ARNOTT; David P. ;   et al. | 2017-10-12 |
Anti-factor D Antibody Variant Conjugates And Uses Thereof App 20170143843 - Hass; Philip E. ;   et al. | 2017-05-25 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20170088596 - SCHEER; Justin ;   et al. | 2017-03-30 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20170073409 - ARNOTT; David P. ;   et al. | 2017-03-16 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20170008942 - SCHEER; Justin ;   et al. | 2017-01-12 |
Anti-interleukin-33 Antibodies And Uses Thereof App 20160168242 - HASS; Philip E. ;   et al. | 2016-06-16 |
Anti-Factor D Antibody Variants and Uses Thereof App 20160017052 - Kelley; Robert F. ;   et al. | 2016-01-21 |
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20140314711 - SCHEER; JUSTIN ;   et al. | 2014-10-23 |
Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20110318301 - Arnott; David P. ;   et al. | 2011-12-29 |
IL-17A/F heterologous polypeptides and therapeutic uses thereof App 20080161540 - Arnott; David P. ;   et al. | 2008-07-03 |
Methods of treating coagulapathic or thrombotic disorders Grant 7,354,585 - Adams , et al. April 8, 2 | 2008-04-08 |
IL-17A/F heterologous polypeptides and therapeutic uses thereof App 20070160576 - Arnott; David P. ;   et al. | 2007-07-12 |
IL-17A/F heterologous polypeptides and therapeutic uses thereof App 20060270003 - Arnott; David P. ;   et al. | 2006-11-30 |
Human anti-factor IX/IXa antibodies App 20060193851 - Adams; Camellia W. ;   et al. | 2006-08-31 |
Human anti-factor IX/IXa antibodies Grant 7,049,411 - Adams , et al. May 23, 2 | 2006-05-23 |
Human Anti-factor Ix/ixa Antibodies App 20060088534 - Adams; Camellia W. ;   et al. | 2006-04-27 |
Human anti-factor IX/IXa antibodies Grant 6,624,295 - Adams , et al. September 23, 2 | 2003-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.